Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × EBV Lymphomas × Ganciclovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 2 Ovarian Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Liver Neoplasms 1 Leukemia 1 Fallopian Tube Neoplasms 1 EBV Lymphomas 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1

Interventions

arginine butyrate 1 Valganciclovir 1 Ganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00917826 2011-08-01

Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies

HemaQuest Pharmaceuticals Inc.

Phase 2 Terminated

EBV Lymphomas

Data powered by HemOnc (CC BY 4.0) Colophon ⚡